Literature DB >> 31324531

Proteolytic control of genome integrity at the replication fork.

Julie Rageul1, Alexandra S Weinheimer2, Jennifer J Park1, Hyungjin Kim3.   

Abstract

Faithful duplication of the genome is critical for the survival of an organism and prevention of malignant transformation. Accurate replication of a large amount of genetic information in a timely manner is one of the most challenging cellular processes and is often perturbed by intrinsic and extrinsic barriers to DNA replication fork progression, a phenomenon referred to as DNA replication stress. Elevated DNA replication stress is a primary source of genomic instability and one of the key hallmarks of cancer. Therefore, targeting DNA replication stress is an emerging concept for cancer therapy. The replication machinery associated with PCNA and other regulatory factors coordinates the synthesis and repair of DNA strands at the replication fork. The dynamic interaction of replication protein complexes with DNA is essential for sensing and responding to various signaling events relevant to DNA replication and damage. Thus, the disruption of the spatiotemporal regulation of protein homeostasis at the replication fork impairs genome integrity, which often involves the deregulation of ubiquitin-mediated proteolytic signaling. Notably, emerging evidence has highlighted the role of the AAA+ATPase VCP/p97 in extracting ubiquitinated protein substrates from the chromatin and facilitating the turnover of genome surveillance factors during DNA replication and repair. Here, we review recent advances in our understanding of chromatin-associated degradation pathways at the replication fork and the implication of these findings for cancer therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA replication; Fanconi anemia; Genome stability; PCNA; Ubiquitin; VCP/p97

Year:  2019        PMID: 31324531      PMCID: PMC6764890          DOI: 10.1016/j.dnarep.2019.102657

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  146 in total

Review 1.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

2.  EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.

Authors:  Beatrice Rondinelli; Ewa Gogola; Hatice Yücel; Alexandra A Duarte; Marieke van de Ven; Roxanne van der Sluijs; Panagiotis A Konstantinopoulos; Jos Jonkers; Raphaël Ceccaldi; Sven Rottenberg; Alan D D'Andrea
Journal:  Nat Cell Biol       Date:  2017-10-16       Impact factor: 28.824

3.  Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.

Authors:  Danielle N Yarde; Vasco Oliveira; Linda Mathews; Xingyu Wang; Alejandro Villagra; David Boulware; Kenneth H Shain; Lori A Hazlehurst; Melissa Alsina; Dung-Tsa Chen; Amer A Beg; William S Dalton
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

4.  A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.

Authors:  Anderson T Wang; Taeho Kim; John E Wagner; Brooke A Conti; Francis P Lach; Athena L Huang; Henrik Molina; Erica M Sanborn; Heather Zierhut; Belinda K Cornes; Avinash Abhyankar; Carrie Sougnez; Stacey B Gabriel; Arleen D Auerbach; Stephen C Kowalczykowski; Agata Smogorzewska
Journal:  Mol Cell       Date:  2015-08-06       Impact factor: 17.970

5.  XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4.

Authors:  Daisy Klein Douwel; Rick A C M Boonen; David T Long; Anna A Szypowska; Markus Räschle; Johannes C Walter; Puck Knipscheer
Journal:  Mol Cell       Date:  2014-04-10       Impact factor: 17.970

Review 6.  The Fanconi anaemia pathway: new players and new functions.

Authors:  Raphael Ceccaldi; Prabha Sarangi; Alan D D'Andrea
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-05       Impact factor: 94.444

7.  Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.

Authors:  Ian Gibbs-Seymour; Yasuyoshi Oka; Eeson Rajendra; Brian T Weinert; Lori A Passmore; Ketan J Patel; Jesper V Olsen; Chunaram Choudhary; Simon Bekker-Jensen; Niels Mailand
Journal:  Mol Cell       Date:  2014-12-31       Impact factor: 17.970

Review 8.  Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.

Authors:  Ukhyun Jo; Hyungjin Kim
Journal:  Mol Cells       Date:  2015-07-21       Impact factor: 5.034

9.  Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis.

Authors:  Reeja S Maskey; Karen S Flatten; Cynthia J Sieben; Kevin L Peterson; Darren J Baker; Hyun-Ja Nam; Myoung Shin Kim; Thomas C Smyrk; Yusuke Kojima; Yuka Machida; Annyoceli Santiago; Jan M van Deursen; Scott H Kaufmann; Yuichi J Machida
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

10.  USP7 is a SUMO deubiquitinase essential for DNA replication.

Authors:  Emilio Lecona; Sara Rodriguez-Acebes; Julia Specks; Andres J Lopez-Contreras; Isabel Ruppen; Matilde Murga; Javier Muñoz; Juan Mendez; Oscar Fernandez-Capetillo
Journal:  Nat Struct Mol Biol       Date:  2016-03-07       Impact factor: 15.369

View more
  2 in total

Review 1.  CRL4Cdt2 Ubiquitin Ligase, A Genome Caretaker Controlled by Cdt2 Binding to PCNA and DNA.

Authors:  Muadz Ahmad Mazian; Kumpei Yamanishi; Mohd Zulhilmi Abdul Rahman; Menega Ganasen; Hideo Nishitani
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

2.  USP7 and VCPFAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork.

Authors:  André Franz; Pablo Valledor; Patricia Ubieto-Capella; Domenic Pilger; Antonio Galarreta; Vanesa Lafarga; Alejandro Fernández-Llorente; Guillermo de la Vega-Barranco; Fabian den Brave; Thorsten Hoppe; Oscar Fernandez-Capetillo; Emilio Lecona
Journal:  Cell Rep       Date:  2021-10-12       Impact factor: 9.995

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.